These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6944303)

  • 1. New antitumor antibiotics: 13-methylaclacinomycin A and its derivatives.
    Soga K; Furusho H; Mori S; Oki T
    J Antibiot (Tokyo); 1981 Jun; 34(6):770-3. PubMed ID: 6944303
    [No Abstract]   [Full Text] [Related]  

  • 2. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
    Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
    J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aclacinomycin A: a new antitumor antibiotic].
    Egorov LV; Ivanitskaia LP; Navashin SM
    Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
    [No Abstract]   [Full Text] [Related]  

  • 4. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity.
    Matsuzawa Y; Yoshimoto A; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1341-7. PubMed ID: 6941953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical modification of anthracycline antibiotics. I. Demethoxycarbonylation, 10-epimerization and 4-o-methylation of aclacinomycin A.
    Tanaka H; Yoshioka T; Shimauchi Y; Matsuzawa Y; Oki T; Inui T
    J Antibiot (Tokyo); 1980 Nov; 33(11):1323-30. PubMed ID: 6941951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trisarubicinol, new antitumor anthracycline antibiotic.
    Yoshimoto A; Matsuzawa Y; Matsushita Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Nov; 34(11):1492-4. PubMed ID: 7319909
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of new anthracyclines 10-O-rhodosaminyl beta-rhodomycinone and beta-isorhodomycinone from mild-acid treated culture of obelmycin-producing Streptomyces violaceus.
    Johdo O; Yoshioka T; Takeuchi T; Yoshimoto A
    J Antibiot (Tokyo); 1997 Jun; 50(6):522-5. PubMed ID: 9268010
    [No Abstract]   [Full Text] [Related]  

  • 8. Neothramycins A and B, new antitumor antibiotics.
    Takeuchi T; Miyamoto T; Ishizuka M; Naganawa H; Kondo S
    J Antibiot (Tokyo); 1976 Jan; 29(1):93-6. PubMed ID: 931797
    [No Abstract]   [Full Text] [Related]  

  • 9. New anthracycline antibiotic, 2-hydroxyaclacinomycin A.
    Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Jul; 34(7):916-8. PubMed ID: 6945302
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
    Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
    Cassinelli G; Rivola G; Ruggieri D; Arcamone F; Grein A; Merli S; Spalla C; Casazza AM; Di Marco A; Pratesi G
    J Antibiot (Tokyo); 1982 Feb; 35(2):176-83. PubMed ID: 6951826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties.
    Oki T; Kitamura I; Yoshimoto A; Matsuzawa Y; Shibamoto N; Ogasawara T; Inui T; Takamatsu A; Takeuchi T; Masuda T; Hamada M; Suda H; Ishizuka M; Sawa T; Umezawa H
    J Antibiot (Tokyo); 1979 Aug; 32(8):791-800. PubMed ID: 500500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of 4- and 6-O-methyl-aclacinomycin derivatives and their antitumor activities.
    Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Inui T
    J Antibiot (Tokyo); 1981 Jul; 34(7):905-8. PubMed ID: 7287594
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
    Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunomodulation by antitumor antibiotics].
    Ishizuka M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 18. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction and hydrolysis of 2-hydroxyaclacinomycin A.
    Matsuzawa Y; Oki T
    J Antibiot (Tokyo); 1981 Nov; 34(11):1495-7. PubMed ID: 7319910
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicin producer.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1993 Aug; 46(8):1219-31. PubMed ID: 8407584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.